Puri A

Hammersmith Medicines Research, London, UK.

1 paper

A phase 2 uncontrolled, open-label study of intranasal BPL-003 (5-methoxy-<i>N,N</i>-dimethyltryptamine) in patients with treatment-resistant depression.

Roberts C, Seynaeve M, Ermakova AO +5